Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1991 1
1993 1
1995 1
1996 1
1997 2
1998 2
1999 3
2000 4
2001 5
2002 5
2003 5
2004 7
2005 11
2006 10
2007 11
2008 14
2009 18
2010 15
2011 17
2012 23
2013 36
2014 27
2015 31
2016 34
2017 39
2018 29
2019 51
2020 56
2021 80
2022 94
2023 89
2024 105
2025 1

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

738 results

Results by year

Filters applied: . Clear all
Page 1
Cardiac monocytes and macrophages after myocardial infarction.
Peet C, Ivetic A, Bromage DI, Shah AM. Peet C, et al. Cardiovasc Res. 2020 May 1;116(6):1101-1112. doi: 10.1093/cvr/cvz336. Cardiovasc Res. 2020. PMID: 31841135 Free PMC article. Review.
Despite this, maladaptive ventricular remodelling and subsequent heart failure (HF) following AMI remain a significant clinical challenge, particularly because several pre-clinical strategies to attenuate remodelling have failed to translate into clinical practice. …
Despite this, maladaptive ventricular remodelling and subsequent heart failure (HF) following AMI remain a significant clinica …
Mitochondria in acute myocardial infarction and cardioprotection.
Ramachandra CJA, Hernandez-Resendiz S, Crespo-Avilan GE, Lin YH, Hausenloy DJ. Ramachandra CJA, et al. EBioMedicine. 2020 Jul;57:102884. doi: 10.1016/j.ebiom.2020.102884. Epub 2020 Jul 10. EBioMedicine. 2020. PMID: 32653860 Free PMC article. Review.
Acute myocardial infarction (AMI) and the heart failure (HF) that often follows are among the leading causes of death and disability worldwide. ...In this article, we review the role of mitochondria as key determinants of acute myocardial IRI, and we highlight their …
Acute myocardial infarction (AMI) and the heart failure (HF) that often follows are among the leading causes of death and disa …
The spectrum of post-myocardial infarction care: From acute ischemia to heart failure.
Akhtar KH, Khan MS, Baron SJ, Zieroth S, Estep J, Burkhoff D, Butler J, Fudim M. Akhtar KH, et al. Prog Cardiovasc Dis. 2024 Jan-Feb;82:15-25. doi: 10.1016/j.pcad.2024.01.017. Epub 2024 Jan 17. Prog Cardiovasc Dis. 2024. PMID: 38242191 Review.
Heart failure (HF) is the leading cause of mortality in patients with acute myocardial infarction (AMI), with incidence ranging from 14% to 36% in patients admitted due to AMI. ...This article aims to provide an up-to-date review on the incidence and pathogen …
Heart failure (HF) is the leading cause of mortality in patients with acute myocardial infarction (AMI), with incidence rangin …
Outcomes in diabetic patients treated with SGLT2-Inhibitors with acute myocardial infarction undergoing PCI: The SGLT2-I AMI PROTECT Registry.
Paolisso P, Bergamaschi L, Gragnano F, Gallinoro E, Cesaro A, Sardu C, Mileva N, Foà A, Armillotta M, Sansonetti A, Amicone S, Impellizzeri A, Esposito G, Morici N, Andrea OJ, Casella G, Mauro C, Vassilev D, Galie N, Santulli G, Marfella R, Calabrò P, Pizzi C, Barbato E. Paolisso P, et al. Pharmacol Res. 2023 Jan;187:106597. doi: 10.1016/j.phrs.2022.106597. Epub 2022 Dec 5. Pharmacol Res. 2023. PMID: 36470546 Free PMC article.
The primary endpoint was defined as a composite of cardiovascular death, recurrent AMI, and hospitalization for HF (MACE). Secondary outcomes included i) in-hospital cardiovascular death, recurrent AMI, occurrence of arrhythmias, and contrast-induced acute ki …
The primary endpoint was defined as a composite of cardiovascular death, recurrent AMI, and hospitalization for HF (MACE). Sec …
PRKAR1A and SDCBP Serve as Potential Predictors of Heart Failure Following Acute Myocardial Infarction.
Chen Q, Su L, Liu C, Gao F, Chen H, Yin Q, Li S. Chen Q, et al. Front Immunol. 2022 May 3;13:878876. doi: 10.3389/fimmu.2022.878876. eCollection 2022. Front Immunol. 2022. PMID: 35592331 Free PMC article.
This study aimed at identifying new predictive biomarkers of post-AMI HF and at revealing the pathogenesis of HF involving these marker genes. METHODS AND RESULTS: A transcriptomic dataset of whole blood cells from AMI patients with HF progressi …
This study aimed at identifying new predictive biomarkers of post-AMI HF and at revealing the pathogenesis of HF involv …
Adverse Cardiac Remodelling after Acute Myocardial Infarction: Old and New Biomarkers.
Berezin AE, Berezin AA. Berezin AE, et al. Dis Markers. 2020 Jun 12;2020:1215802. doi: 10.1155/2020/1215802. eCollection 2020. Dis Markers. 2020. PMID: 32626540 Free PMC article. Review.
Numerous studies have examined the diagnostic and prognostic potencies of circulating cardiac biomarkers in acute coronary syndrome/AMI and heart failure after AMI, and even fewer have depicted the utility of biomarkers in AMI patients undergoing primary PCI. …
Numerous studies have examined the diagnostic and prognostic potencies of circulating cardiac biomarkers in acute coronary syndrome/AMI …
β-Blockers and Mortality After Acute Myocardial Infarction in Patients Without Heart Failure or Ventricular Dysfunction.
Dondo TB, Hall M, West RM, Jernberg T, Lindahl B, Bueno H, Danchin N, Deanfield JE, Hemingway H, Fox KAA, Timmis AD, Gale CP. Dondo TB, et al. J Am Coll Cardiol. 2017 Jun 6;69(22):2710-2720. doi: 10.1016/j.jacc.2017.03.578. J Am Coll Cardiol. 2017. PMID: 28571635 Free PMC article.
BACKGROUND: For acute myocardial infarction (AMI) without heart failure (HF), it is unclear if beta-blockers are associated with reduced mortality. ...A total of 179,810 survivors of hospitalization with AMI without HF or LVSD, between January 1, 2007, …
BACKGROUND: For acute myocardial infarction (AMI) without heart failure (HF), it is unclear if beta-blockers are associated wi …
Identification of molecular markers for predicting the severity of heart failure after AMI: An Olink precision proteomic study.
Zhang T, Han X, Zhang H, Li X, Zhou X, Feng S, Guo C, Song F, Tao T, Yin C, Xia J. Zhang T, et al. Clin Chim Acta. 2024 Mar 1;555:117825. doi: 10.1016/j.cca.2024.117825. Epub 2024 Feb 6. Clin Chim Acta. 2024. PMID: 38331209
BACKGROUND: Acute myocardial infarction (AMI) still has a high incidence of varying degrees of heart failure (HF). The aim of this study is to identify new molecular markers for predicting the severity of HF after AMI. ...CONCLUSIONS: Neutrophil count, …
BACKGROUND: Acute myocardial infarction (AMI) still has a high incidence of varying degrees of heart failure (HF). The aim of …
Cardioprotection of Panax Notoginseng saponins against acute myocardial infarction and heart failure through inducing autophagy.
Wang D, Lv L, Xu Y, Jiang K, Chen F, Qian J, Chen M, Liu G, Xiang Y. Wang D, et al. Biomed Pharmacother. 2021 Apr;136:111287. doi: 10.1016/j.biopha.2021.111287. Epub 2021 Jan 20. Biomed Pharmacother. 2021. PMID: 33485065 Free article.
MI remains the most common cause of heart failure (HF) worldwide. Here we demonstrated that Panax Notoginseng saponins (PNS), the extract of Panax notoginseng, exerts cardioprotective effect in AMI and the underlying mechanism refers to inducing cardiomyocyte autoph …
MI remains the most common cause of heart failure (HF) worldwide. Here we demonstrated that Panax Notoginseng saponins (PNS), the ext …
738 results